FNY Managed Accounts’s Gilead Sciences GILD Stock Holding History

FNY Managed Accounts’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-150	Closed	-$10K	–	628
2017 Q2	$10K	Sell	150 -865	-85%	-$57.6K	0.1%	121
2017 Q1	$68K	Buy	+1,015	New	+$71.4K	0.21%	129
2016 Q4	–	Sell	-25	Closed	-$1.98K	–	127
2016 Q3	$1.98K	Buy	+25	New	+$2.03K	﹤0.01%	381
2015 Q4	–	Sell	-2,144	Closed	-$211K	–	255
2015 Q3	$211K	Buy	2,144 +2,000	+1,389%	+$222K	0.59%	45
2015 Q2	$16.9K	Buy	+144	New	+$15.7K	0.02%	265
2014 Q2	–	Sell	-1,940	Closed	-$137K	–	115
2014 Q1	$137K	Buy	+1,940	New	+$152K	0.36%	41

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

FNY Managed Accounts's GILD Position: Q3 2017 in Review

FNY Managed Accounts sold out of Gilead Sciences (GILD) in Q3 2017, closing a stake of 150 shares — an estimated $10K sold.

FNY Managed Accounts first reported a position in GILD in Q1 2014 and held it in 6 quarters. The position peaked at $211K in Q3 2015. 1,503 funds tracked by Wall St. Rank hold GILD as of Q3 2017.

FNY Managed Accounts reported no remaining Gilead Sciences position as of Q3 2017 after selling out during the quarter.
FNY Managed Accounts sold 150 Gilead Sciences shares in Q3 2017, an estimated $10K.
FNY Managed Accounts first reported a position in Gilead Sciences in Q1 2014 and held it in 6 quarters.
FNY Managed Accounts's Gilead Sciences position peaked at $211K in Q3 2015.
1,503 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2017.

Based on FNY Managed Accounts's 13F filing for Q3 2017, filed 9 Nov 2017.